Schrodinger, INC Form 4 insider transactions
NASDAQ
SDGR
Schrodinger, INCYvonne Tran, EVP, CLO & CPO of Schrodinger, Inc., reports the acquisition of 60,000 stock options on March 4, 2024.
NASDAQ
SDGR
Schrodinger, INCMargaret Dugan, Chief Medical Officer of Schrodinger, Inc., was granted 60,000 stock options on March 4, 2024, according to a Form 4 filing with the SEC.
NASDAQ
SDGR
Schrodinger, INCRobert Lorne Abel, EVP and Chief Scientific Officer at Schrodinger, Inc., reported the grant of stock options on March 4, 2024.